Combined respiratory system compliance US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for Combined respiratory system compliance. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Combined respiratory system compliance US Medical PG Question 1: An 85-year-old man with hypertension and type 2 diabetes mellitus is brought to the emergency department because of a 2-day history of shortness of breath. He has smoked one pack of cigarettes daily for 30 years. His temperature is 36.9°C (98.4°F), pulse is 100/min, respirations are 30/min, and blood pressure is 138/75 mm Hg. Pulmonary function testing shows decreased tidal volume and normal lung compliance. Which of the following is the most likely underlying etiology of this patient's tachypnea?
- A. Diabetic ketoacidosis
- B. Rib fracture
- C. Pulmonary edema (Correct Answer)
- D. Emphysema exacerbation
- E. Tension pneumothorax
Combined respiratory system compliance Explanation: ***Pulmonary edema***
- This patient's **hypertension** and **diabetes** are major risk factors for heart failure, and the acute onset of **shortness of breath** with **tachypnea** suggests cardiogenic pulmonary edema.
- **Decreased tidal volume** occurs because fluid accumulation in the interstitium and alveoli reduces functional lung capacity, prompting rapid, shallow breathing to maintain minute ventilation.
- While pulmonary edema typically causes **decreased lung compliance** due to fluid-stiffened lungs, early or mild cases may show relatively preserved compliance, or the normal compliance here may reflect measurement timing or technique. The clinical picture and decreased tidal volume strongly support pulmonary edema.
- The combination of cardiac risk factors, acute dyspnea, tachypnea, and altered breathing pattern make this the most likely diagnosis.
*Diabetic ketoacidosis*
- DKA causes **Kussmaul respirations** (deep, labored breathing) to compensate for metabolic acidosis, not the shallow breathing pattern (decreased tidal volume) seen here.
- DKA typically presents with polyuria, polydipsia, abdominal pain, nausea, and fruity breath odor, which are not mentioned.
- While this patient has diabetes, the respiratory pattern and absence of typical DKA symptoms make this less likely.
*Rib fracture*
- Rib fractures cause **pleuritic chest pain** that worsens with breathing, leading to voluntary splinting and reduced tidal volume.
- However, there is **no history of trauma** or chest pain reported.
- Pain from rib fractures would be localized, and the acute 2-day onset of dyspnea without trauma makes this unlikely.
*Emphysema exacerbation*
- Emphysema is characterized by **increased lung compliance** (hyperinflation) due to alveolar wall destruction, which contradicts the normal compliance finding.
- While the patient has a significant smoking history, the **normal lung compliance** argues against emphysema.
- COPD exacerbations typically present with wheezing, productive cough, and hyperinflation, not decreased tidal volume with normal compliance.
*Tension pneumothorax*
- Tension pneumothorax presents with **severe respiratory distress**, unilateral absent breath sounds, **hypotension**, tracheal deviation, and jugular venous distension.
- This patient's **blood pressure is normal** (138/75 mm Hg) and there's no mention of absent breath sounds or hemodynamic compromise.
- The clinical presentation does not support this life-threatening emergency.
Combined respiratory system compliance US Medical PG Question 2: A 35-year-old woman volunteers for a study on respiratory physiology. Pressure probes A and B are placed as follows:
Probe A: between the parietal and visceral pleura
Probe B: within the cavity of an alveolus
The probes provide a pressure reading relative to atmospheric pressure. To obtain a baseline reading, she is asked to sit comfortably and breathe normally. Which of the following sets of values will most likely be seen at the end of inspiration?
- A. Probe A: -6 mm Hg; Probe B: 0 mm Hg (Correct Answer)
- B. Probe A: 0 mm Hg; Probe B: -1 mm Hg
- C. Probe A: -4 mm Hg; Probe B: 0 mm Hg
- D. Probe A: -4 mm Hg; Probe B: -1 mm Hg
- E. Probe A: -6 mm Hg; Probe B: -1 mm Hg
Combined respiratory system compliance Explanation: ***Probe A: -6 mm Hg; Probe B: 0 mm Hg***
- At the **end of inspiration**, the **intrapleural pressure (Probe A)** is at its most negative, typically around -6 to -8 cm H2O (equivalent to -4 to -6 mmHg), reflecting the maximum expansion of the thoracic cavity.
- At the **end of inspiration**, just before exhalation begins, there is **no airflow**, so the **intrapulmonary pressure (Probe B)** equalizes with atmospheric pressure, resulting in a 0 mm Hg reading.
*Probe A: 0 mm Hg; Probe B: -1 mm Hg*
- An **intrapleural pressure of 0 mm Hg** would indicate a **pneumothorax** since it should always be negative to prevent lung collapse.
- An **intrapulmonary pressure of -1 mm Hg** would indicate that **inspiration is still ongoing**, as air would be flowing into the lungs.
*Probe A: -4 mm Hg; Probe B: 0 mm Hg*
- While an **intrapulmonary pressure of 0 mm Hg** is correct at the end of inspiration, an **intrapleural pressure of -4 mm Hg** is typical for the **end of expiration (Functional Residual Capacity)** during quiet breathing, not the end of inspiration.
- The **intrapleural pressure becomes more negative** during inspiration due to increased thoracic volume, so -4 mm Hg would be insufficient.
*Probe A: -4 mm Hg; Probe B: -1 mm Hg*
- An **intrapleural pressure of -4 mm Hg** is the normal pressure at the **end of expiration**, not the end of inspiration, where it becomes more negative.
- An **intrapulmonary pressure of -1 mm Hg** indicates that **inspiration is still in progress**, not at its end, as air would still be flowing into the lungs.
*Probe A: -6 mm Hg; Probe B: -1 mm Hg*
- While an **intrapleural pressure of -6 mm Hg** is consistent with the end of inspiration, an **intrapulmonary pressure of -1 mm Hg** means that **airflow is still occurring into the lungs**.
- At the **very end of inspiration**, just before the start of exhalation, airflow momentarily ceases, and intrapulmonary pressure becomes zero relative to the atmosphere.
Combined respiratory system compliance US Medical PG Question 3: A 57-year-old man comes to the physician because of a 2-year history of fatigue, worsening shortness of breath, and a productive cough for 2 years. He has smoked 1 pack of cigarettes daily for the past 40 years. Examination shows pursed-lip breathing and an increased anteroposterior chest diameter. There is diffuse wheezing bilaterally and breath sounds are distant. Which of the following parameters is most likely to be decreased in this patient?
- A. Thickness of small airways
- B. Work of breathing
- C. Lung elastic recoil (Correct Answer)
- D. Lower airway resistance
- E. Pulmonary vascular pressure
Combined respiratory system compliance Explanation: ***Lung elastic recoil***
- The patient's presentation (long smoking history, dyspnea, pursed-lip breathing, increased AP diameter, distant breath sounds, and wheezing) is classic for **emphysema**, a form of **COPD**.
- Emphysema involves the destruction of **alveolar walls** and **elastic fibers**, leading to a significant decrease in the lung's ability to passively recoil during expiration.
*Thickness of small airways*
- In COPD, particularly chronic bronchitis, there is often **inflammation and thickening of the small airways** due to goblet cell hyperplasia and mucus gland hypertrophy, increasing their thickness, not decreasing it.
- This thickening contributes to increased airway resistance.
*Work of breathing*
- The **destruction of elastic recoil** in emphysema means the patient must actively use accessory muscles to exhale, significantly **increasing the work of breathing**, which is evident from pursed-lip breathing.
- Patients with COPD expend much more energy to breathe than healthy individuals.
*Lower airway resistance*
- Emphysema, while characterized by alveolar destruction, also has an obstructive component due to **airway collapse during expiration** (loss of radial traction) and potential inflammation/mucus, which leads to **increased lower airway resistance**, not decreased resistance.
- This increased resistance contributes to air trapping and wheezing.
*Pulmonary vascular pressure*
- Chronic hypoxia resulting from severe COPD can lead to **pulmonary vasoconstriction** and remodeling of the pulmonary arteries, causing **pulmonary hypertension** and an increase in pulmonary vascular pressure.
- This is a common complication in advanced COPD, not a decreased parameter.
Combined respiratory system compliance US Medical PG Question 4: In which of the following pathological states would the oxygen content of the trachea resemble the oxygen content in the affected alveoli?
- A. Emphysema
- B. Exercise
- C. Pulmonary embolism (Correct Answer)
- D. Pulmonary fibrosis
- E. Foreign body obstruction distal to the trachea
Combined respiratory system compliance Explanation: ***Pulmonary embolism***
- A pulmonary embolism blocks **blood flow** to a portion of the lung, creating **dead space ventilation** (high V/Q ratio).
- In the affected alveoli, **no blood perfusion** means no oxygen extraction occurs, so the alveolar oxygen content remains **high and similar to tracheal/inspired air**.
- This is the classic physiological state where ventilation continues but perfusion is absent, preventing gas exchange.
*Foreign body obstruction distal to the trachea*
- A complete obstruction **prevents fresh air** from reaching the affected alveoli.
- The trapped gas undergoes **resorption atelectasis**: oxygen is absorbed into capillary blood, CO2 diffuses in, and alveolar gas equilibrates with **venous blood** composition.
- Alveolar oxygen content becomes **very low**, not similar to tracheal air.
*Emphysema*
- Emphysema involves destruction of **alveolar walls** and enlargement of airspaces with impaired gas exchange.
- While V/Q mismatch occurs, oxygen is still extracted by perfusing blood.
- Alveolar oxygen content is **lower than tracheal air** due to ongoing (though inefficient) gas exchange.
*Exercise*
- During exercise, **oxygen consumption increases** dramatically with enhanced cardiac output and oxygen extraction.
- Alveolar oxygen content is **significantly lower** than tracheal air due to increased oxygen uptake by blood.
*Pulmonary fibrosis*
- Pulmonary fibrosis causes **thickening of the alveolar-capillary membrane**, impairing oxygen diffusion.
- Despite diffusion limitation, blood still perfuses the alveoli and extracts oxygen.
- Alveolar oxygen content is **lower than tracheal air**, though the A-a gradient is increased.
Combined respiratory system compliance US Medical PG Question 5: A 60-year-old man presents with breathlessness for the past 3 months. His symptoms have been getting progressively worse during this time. He denies any history of cough, fever, or chest pain. He works at a local shipyard and is responsible for installing the plumbing aboard the vessels. His past medical history is significant for hypertension for which he takes metoprolol every day. He denies smoking and any illicit drug use. His pulse is 74/min, respiratory rate is 14/min, blood pressure is 130/76 mm Hg, and temperature is 36.8°C (98.2°F). Physical examination is significant for fine bibasilar crackles at the end of inspiration without digital clubbing. Which of the following additional findings would most likely be present in this patient?
- A. Increased pulmonary capillary wedge pressure
- B. Increased residual lung volume
- C. Reduced FEV1/FVC ratio
- D. Decreased diffusing capacity of CO (Correct Answer)
- E. Decreased pulmonary arterial pressure
Combined respiratory system compliance Explanation: ***Decreased diffusing capacity of CO***
- This patient's occupation at a **shipyard**, progressive dyspnea, and bibasilar crackles without clubbing, along with normal vital signs, are highly suggestive of **asbestosis**, a type of **interstitial lung disease (ILD)**.
- ILDs cause **fibrosis of the alveolar-capillary membrane**, leading to impaired gas exchange and a characteristic **reduction in DLCO (diffusing capacity of the lung for carbon monoxide)**. This is a hallmark of parenchymal lung disease.
*Increased pulmonary capillary wedge pressure*
- An elevated **pulmonary capillary wedge pressure (PCWP)** indicates **left-sided heart failure** or **pulmonary venous hypertension**.
- While dyspnea can be a symptom of heart failure, the patient's normal blood pressure and absence of cardiac-specific symptoms or signs point away from primary cardiac pathology.
*Increased residual lung volume*
- **Increased residual lung volume** is a characteristic finding in **obstructive lung diseases** such as **COPD** and **asthma**, where there is air trapping due to airflow limitation.
- The patient's presentation with progressive dyspnea and bibasilar crackles is more consistent with a **restrictive lung disorder** like asbestosis, which typically causes **decreased lung volumes**.
*Reduced FEV1/FVC ratio*
- A **reduced FEV1/FVC ratio** is the hallmark of **obstructive lung diseases**, indicating airflow limitation.
- In **restrictive lung diseases** like asbestosis, both FEV1 and FVC are typically reduced proportionally, often resulting in a **normal or even increased FEV1/FVC ratio**.
*Decreased pulmonary arterial pressure*
- **Pulmonary arterial pressure (PAP)** is typically **normal or increased** in patients with interstitial lung disease due to **hypoxic vasoconstriction** and vascular remodeling.
- A decreased PAP would be an unusual and atypical finding in such a patient and is not associated with this clinical picture.
Combined respiratory system compliance US Medical PG Question 6: A 30-year-old woman presents to the emergency department with breathlessness for the last hour. She is unable to provide any history due to her dyspnea. Her vitals include: respiratory rate 20/min, pulse 100/min, and blood pressure 144/84 mm Hg. On physical examination, she is visibly obese, and her breathing is labored. There are decreased breath sounds and hyperresonance to percussion across all lung fields bilaterally. An arterial blood gas is drawn, and the patient is placed on inhaled oxygen. Laboratory findings reveal:
pH 7.34
pO2 63 mm Hg
pCO2 50 mm Hg
HCO3 22 mEq/L
Her alveolar partial pressure of oxygen is 70 mm Hg. Which of the following is the most likely etiology of this patient’s symptoms?
- A. Right to left shunt
- B. Alveolar hypoventilation (Correct Answer)
- C. Ventricular septal defect
- D. Impaired gas diffusion
- E. Ventilation/perfusion mismatch
Combined respiratory system compliance Explanation: ***Alveolar hypoventilation***
- The patient exhibits features of **obesity** and **labored breathing** with decreased breath sounds and hyperresonance, along with arterial blood gas results showing **respiratory acidosis** (pH 7.34, pCO2 50 mmHg) and **hypoxia** (pO2 63 mmHg).
- The calculated A-a gradient (Alveolar O2 - arterial O2) is low (70 mmHg - 63 mmHg = 7 mmHg), indicating that the problem is primarily with **overall ventilation** rather than a defect in gas exchange across the alveolar-capillary membrane.
*Right to left shunt*
- A right-to-left shunt would cause a **large A-a gradient**, as deoxygenated blood bypasses the lungs and mixes with oxygenated blood.
- While it causes **hypoxemia**, it would not typically be associated with hypercapnia unless very severe, and the A-a gradient calculation here does not support a significant shunt.
*Ventricular septal defect*
- A ventricular septal defect is a **structural heart abnormality** that can cause a left-to-right shunt initially, leading to pulmonary hypertension and eventually a right-to-left shunt (Eisenmenger syndrome).
- While it can cause hypoxemia due to shunting, it would not primarily manifest with increased pCO2 or the specific lung physical exam findings of decreased breath sounds and hyperresonance in the absence of other cardiac signs.
*Impaired gas diffusion*
- Impaired gas diffusion would lead to a **large A-a gradient** and **hypoxemia**, but typically not significant hypercapnia unless the impairment is extremely severe.
- Conditions like **pulmonary fibrosis** or **emphysema** cause impaired diffusion, but the patient's presentation and particularly the low A-a gradient do not support this.
*Ventilation/perfusion mismatch*
- A V/Q mismatch also causes a **large A-a gradient** and **hypoxemia**, as some areas of the lung are either poorly ventilated or poorly perfused.
- While it can cause hypercapnia in severe cases, the primary issue indicated by the low A-a gradient here is one of overall inadequate ventilation, not selective areas of ventilation-perfusion imbalance.
Combined respiratory system compliance US Medical PG Question 7: A 57-year-old man presents to the clinic for a chronic cough over the past 4 months. The patient reports a productive yellow/green cough that is worse at night. He denies any significant precipitating event prior to his symptoms. He denies fever, chest pain, palpitations, weight changes, or abdominal pain, but endorses some difficulty breathing that waxes and wanes. He denies alcohol usage but endorses a 35 pack-year smoking history. A physical examination demonstrates mild wheezes, bibasilar crackles, and mild clubbing of his fingertips. A pulmonary function test is subsequently ordered, and partial results are shown below:
Tidal volume: 500 mL
Residual volume: 1700 mL
Expiratory reserve volume: 1500 mL
Inspiratory reserve volume: 3000 mL
What is the functional residual capacity of this patient?
- A. 4500 mL
- B. 2000 mL
- C. 2200 mL
- D. 3200 mL (Correct Answer)
- E. 3500 mL
Combined respiratory system compliance Explanation: ***3200 mL***
- The **functional residual capacity (FRC)** is the volume of air remaining in the lungs after a normal expiration.
- It is calculated as the sum of the **expiratory reserve volume (ERV)** and the **residual volume (RV)**. In this case, 1500 mL (ERV) + 1700 mL (RV) = 3200 mL.
*4500 mL*
- This value represents the sum of the **inspiratory reserve volume (3000 mL)** and the **residual volume (1700 mL)**, which does not correspond to a standard lung volume or capacity.
- It does not logically relate to the definition of functional residual capacity.
*2000 mL*
- This value represents the sum of the **tidal volume (500 mL)** and the **expiratory reserve volume (1500 mL)**, which is incorrect for FRC.
- This would represent the inspiratory capacity minus the inspiratory reserve volume, which is not a standard measurement used in pulmonary function testing.
*2200 mL*
- This value could be obtained by incorrectly adding the **tidal volume (500 mL)** and the **residual volume (1700 mL)**, which is not the correct formula for FRC.
- This calculation represents a miscombination of lung volumes that does not correspond to any standard pulmonary capacity measurement.
*3500 mL*
- This value is the sum of the **tidal volume (500 mL)**, the **expiratory reserve volume (1500 mL)**, and the **residual volume (1700 mL)**.
- This would represent the FRC plus the tidal volume, which is not a standard measurement and does not represent the functional residual capacity.
Combined respiratory system compliance US Medical PG Question 8: A 68-year-old man comes to the emergency room with difficulty in breathing. He was diagnosed with severe obstructive lung disease a few years back. He uses his medication but often has to come to the emergency room for intravenous therapy to help him breathe. He was a smoker for 40 years smoking two packs of cigarettes every day. Which of the following best represents the expected changes in his ventilation, perfusion and V/Q ratio?
- A. Normal ventilation, low or nonexistent perfusion and infinite V/Q ratio
- B. Medium ventilation and perfusion, V/Q that equals 0.8
- C. Higher ventilation and perfusion with lower V/Q ratio
- D. Low ventilation, normal perfusion and low V/Q ratio (Correct Answer)
- E. Lower ventilation and perfusion, but higher V/Q ratio
Combined respiratory system compliance Explanation: ***Low ventilation, normal perfusion and low V/Q ratio***
- In severe **obstructive lung disease** (like COPD), there is airflow limitation, leading to areas of **hypoventilation** in the lungs.
- While ventilation is compromised, blood flow (perfusion) to these areas can remain relatively normal, resulting in a **decreased V/Q ratio**.
*Normal ventilation, low or nonexistent perfusion and infinite V/Q ratio*
- This scenario describes a lung unit with **dead space ventilation**, where there is ventilation but no blood flow (e.g., in a pulmonary embolism).
- The patient's history of **obstructive lung disease** primarily indicates impaired airflow, not a lack of perfusion.
*Medium ventilation and perfusion, V/Q that equals 0.8*
- A **V/Q ratio of 0.8** represents the **ideal normal** ventilation-perfusion matching in a healthy lung.
- The patient has severe obstructive lung disease, which by definition means there is significant mismatch, not normal physiology.
*Higher ventilation and perfusion with lower V/Q ratio*
- While hyperventilation can occur in attempts to compensate, the primary issue in obstructive disease is **impaired ventilation**, not increased ventilation, leading to decreased gas exchange.
- A lower V/Q ratio is expected, but it is driven by **low ventilation**, not higher ventilation and perfusion.
*Lower ventilation and perfusion, but higher V/Q ratio*
- Although both ventilation and perfusion can be affected in severe disease, a **higher V/Q ratio** typically implies areas of increased dead space (more ventilation than perfusion).
- In obstructive disease, the predominant problem is **impaired air entry**, leading to underventilated units with relatively preserved perfusion, thus a **low V/Q ratio**.
Combined respiratory system compliance US Medical PG Question 9: A 68-year-old man with both severe COPD (emphysema) and newly diagnosed idiopathic pulmonary fibrosis presents with worsening dyspnea. His pressure-volume curve shows a complex pattern with features of both diseases. Static compliance measured at mid-lung volumes is 120 mL/cm H2O. His pulmonologist must decide on optimal management. Synthesizing the pathophysiology of both conditions, what represents the most significant clinical challenge in managing his combined disease?
- A. Pulmonary rehabilitation cannot address the opposing mechanical derangements
- B. The increased compliance from emphysema completely negates decreased compliance from fibrosis
- C. The opposing effects on compliance create a pseudonormal total respiratory compliance masking disease severity (Correct Answer)
- D. Emphysema treatment with bronchodilators will worsen fibrosis progression
- E. Oxygen therapy beneficial for COPD will accelerate fibrotic changes
Combined respiratory system compliance Explanation: ***The opposing effects on compliance create a pseudonormal total respiratory compliance masking disease severity***
- In **Combined Pulmonary Fibrosis and Emphysema (CPFE)**, the **increased lung compliance** from upper-lobe emphysema is offset by the **decreased compliance** from lower-lobe fibrosis.
- This results in a **pseudonormalization** of lung volumes (like FVC and TLC) and compliance measurements, which can lead to a significant **underestimation of disease severity** during clinical assessment.
*Pulmonary rehabilitation cannot address the opposing mechanical derangements*
- While mechanical derangements are complex, **pulmonary rehabilitation** remains a cornerstone of management to improve functional capacity and reduce dyspnea in both conditions.
- The challenge is not that rehabilitation is ineffective, but rather the **physiological monitoring** and objective assessment of progress are hampered by masked lung volumes.
*The increased compliance from emphysema completely negates decreased compliance from fibrosis*
- The two forces do not perfectly negate each other; rather, they coexist to produce a **paradoxical physiological profile** where static measurements appear mid-range while gas exchange is severely impaired.
- Patients often exhibit a **disproportionate reduction in DLCO** (diffusion capacity) despite relatively preserved lung volumes, indicating the negation is only superficial and numerical.
*Emphysema treatment with bronchodilators will worsen fibrosis progression*
- There is no clinical evidence suggesting that **bronchodilators** (beta-agonists or anticholinergics) used for COPD/emphysema accelerate the **pathological scarring** seen in idiopathic pulmonary fibrosis.
- Bronchodilators primarily target **airway smooth muscle** and do not interfere with the fibroblastic pathways driving interstitial lung disease.
*Oxygen therapy beneficial for COPD will accelerate fibrotic changes*
- **Long-term oxygen therapy (LTOT)** is used to treat chronic hypoxemia in both COPD and fibrosis and does not cause or accelerate **lung remodeling** or fibrosis.
- While high concentrations of inspired oxygen (FiO2) can cause **oxidative stress**, the flow rates used for clinical management do not contribute to the progression of pulmonary fibrosis.
Combined respiratory system compliance US Medical PG Question 10: A 42-year-old woman with systemic sclerosis develops both pulmonary fibrosis and chest wall restriction from skin thickening. Her measured total respiratory system compliance is 30 mL/cm H2O. Testing with complete paralysis and positive pressure ventilation shows isolated lung compliance of 50 mL/cm H2O. She is being considered for immunosuppressive therapy versus supportive care. Evaluate which intervention would provide the greatest improvement in her respiratory mechanics.
- A. Supportive care only, as both components contribute equally and irreversibly
- B. Combined therapy targeting lung disease with chest wall mobilization (Correct Answer)
- C. Aggressive immunosuppression targeting both lung and skin disease
- D. Lung-directed therapy only, as it contributes more to total compliance reduction
- E. Chest wall-directed physical therapy, as it is the primary limiting factor
Combined respiratory system compliance Explanation: ***Combined therapy targeting lung disease with chest wall mobilization*** - The total respiratory compliance (Ct) is calculated using the formula **1/Ct = 1/Clung + 1/Cchest wall**; here, 1/30 = 1/50 + 1/Ccw, which calculates the **chest wall compliance** as 75 mL/cm H2O. - Both the lungs (50 mL/cm H2O) and chest wall (75 mL/cm H2O) are significantly below the **normal value of ~200 mL/cm H2O**, meaning both require intervention for meaningful improvement. *Supportive care only, as both components contribute equally and irreversibly* - While both contribute, they are not strictly equal (50 vs 75), and **systemic sclerosis**-associated lung/skin disease may respond to modern therapeutic interventions. - Labeling these as **irreversible** ignores potential benefits from immunosuppression in the active inflammatory stages of **interstitial lung disease**. *Aggressive immunosuppression targeting both lung and skin disease* - While immunosuppression addresses the underlying **pathophysiology**, it may not provide immediate mechanical relief for fixed **chest wall restriction**. - Effective management often requires adding **physical therapy** and mobilization to address the extrinsic mechanical constraint caused by **scleroderma skin thickening**. *Lung-directed therapy only, as it contributes more to total compliance reduction* - Although lung compliance (50) is lower than chest wall compliance (75), ignoring the **chest wall component** neglects a significant portion of the patient's **work of breathing**. - Solely treating the lung disease will not bypass the **extrinsic restriction** imposed by the tight skin and musculoskeletal changes. *Chest wall-directed physical therapy, as it is the primary limiting factor* - The calculations show that **lung compliance** is actually more severely reduced (50) than chest wall compliance (75). - Focusing only on the **chest wall** would leave the primary cause of the **restrictive ventilatory defect** (pulmonary fibrosis) unaddressed.
More Combined respiratory system compliance US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
